J & amp;J raises U.S. drug prices
Johnson& Johnson raised U.S. prices on around two dozen drugs, including psoriasis treatment, Stelara, prostate cancer drug, Zytiga, and blood thinner, Xarelto. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - January 11, 2019 Category: Pharmaceuticals Source Type: news
J & J raises U.S. prices on around two dozen drugs
Johnson& Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among its top-selling products. (Source: Reuters: Health)
Source: Reuters: Health - January 10, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
U.S. appeals court declines J & J bid to stop generic Zytiga sales
A U.S. appeals court on Wednesday declined a request by Johnson& Johnson for an temporary restraining order blocking sales of generic versions of its cancer drug Zytiga from hitting the U.S. market. (Source: Reuters: Health)
Source: Reuters: Health - November 21, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Court Issues Ruling in ZYTIGA ® Patent Infringement Litigation
(Source: Johnson and Johnson)
Source: Johnson and Johnson - October 26, 2018 Category: Pharmaceuticals Source Type: news
Johnson & Johnson edges past profit estimates, lifts outlook
Johnson& Johnson reported slightly better-than-expected quarterly profit on Tuesday and pushed its full-year forecast higher, as demand for its cancer drugs Zytiga and Imbruvica helped offset falling sales of arthritis treatment Remicade. (Source: Reuters: Health)
Source: Reuters: Health - October 16, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Johnson & Johnson profit beats, lifts forecast on cancer drug demand
Johnson& Johnson on Tuesday reported quarterly profit above estimates and raised its full-year forecast, as demand for its cancer drugs Zytiga and Imbruvica helped offset decline in sales of blockbuster drug, Remicade. (Source: Reuters: Health)
Source: Reuters: Health - October 16, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Johnson & Johnson profit beat fueled by strength in pharma business
Johnson& Johnson topped analysts' estimates for quarterly profit and revenue on Tuesday, as strong demand for cancer drugs Zytiga and Darzalex more than made up for declining sales of blockbuster treatment Remicade. (Source: Reuters: Health)
Source: Reuters: Health - July 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news
Yonsa (Abiraterone Acetate Tablets) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 7, 2018 Category: Drugs & Pharmacology Source Type: news
Sun Pharma Announces FDA Approval of Yonsa (abiraterone acetate) to Treat Metastatic Castration-Resistant Prostate Cancer
MUMBAI& PRINCETON, N.J.& KING OF PRUSSIA, Pa. May 23, 2018 --(BUSINESS WIRE)--Sun Pharmaceutical Industries Ltd. and includes its subsidiaries and/or associate companies) and Churchill Pharmaceuticals, LLC. (Churchill) today announced that... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 23, 2018 Category: Drugs & Pharmacology Source Type: news
Low-Dose Prostate Drug Can Match Standard Dose, Cut Costs Low-Dose Prostate Drug Can Match Standard Dose, Cut Costs
Patients who cannot afford to take abiraterone acetate for metastatic castration-resistant prostate cancer could benefit just as much from taking just a quarter dose with food, say US researchers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 18, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Medical News Today: Prostate cancer: How a full stomach could improve treatment
A new study finds that the prostate cancer drug Zytiga is more effective, as well as cheaper, when taken with food, as opposed to on an empty stomach. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - April 2, 2018 Category: Consumer Health News Tags: Prostate / Prostate Cancer Source Type: news
Full English could make prostate cancer treatment more effective
Current NHS guidelines for the drug abiraterone - also known as Zytiga - say it must be taken on an empty stomach. (Source: the Mail online | Health)
Source: the Mail online | Health - March 29, 2018 Category: Consumer Health News Source Type: news
Full English breakfast could make prostate cancer treatment more effective
Current NHS guidelines for the drug abiraterone - also known as Zytiga - say it must be taken on an empty stomach. (Source: the Mail online | Health)
Source: the Mail online | Health - March 29, 2018 Category: Consumer Health News Source Type: news
Low - Dose Abiraterone Acetate Noninferior for Prostate Cancer
Low - dose AA with low - fat breakfast had greater effect on PSA; similar effect to standard dose (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 29, 2018 Category: Cancer & Oncology Tags: Oncology, Pharmacy, Urology, Journal, Source Type: news
Low-Dose Abiraterone Acetate Noninferior for Prostate Cancer
WEDNESDAY, March 28, 2018 -- For castration-resistant prostate cancer (CRPC), low-dose abiraterone acetate (AA) with a low-fat breakfast is noninferior to standard dose with fasting in terms of the mean change in prostate-specific antigen (PSA),... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 28, 2018 Category: Pharmaceuticals Source Type: news
